From Public Repositories to Target Hypotheses – An End-to-End Data-to-Insights Journey for scRNA and Spatial Omics with Knowledge Graphs

Format:

From Public Repositories to Target Hypotheses An End-to-End Data-to-Insights Journey for scRNA and Spatial Omics with Knowledge Graphs

About the poster

Single-cell and spatial datasets hold immense potential but are hindered by curation bottlenecks and incompatible annotations. We present a scalable “Data-to-Insights Journey” that converts these sources into actionable target hypotheses through three core pillars.

1) LLM-augmented ETL, combined with atlas generation workflow, reduces processing time from days to minutes, retaining 90% accuracy. It addresses data fragmentation by unifying metadata and establishing common standards.

2) A scientist-ready browser for immediate access to AI-ready data products, for biologists to visually explore and validate datasets without coding.

3) Multiomics target ranking algorithm drives discovery by integrating single-cell data with other modalities. It synthesizes this multimodal landscape into prioritized targets. Furthermore refines the ranking with knowledge-based second line of evidence.

This end-to-end workflow accelerates the transition from raw data to reproducible insights, and has resulted in a discovery of a novel target that was later validated.

Poster was presented at Festival of Genomics and Biodata, London, 2026

You might be also interested in:

Biomedical knowledge graph connecting drug discovery data, disease biology, targets and indications to support target prioritization and indication expansion
Knowledge Graphs in Drug Discovery: Bringing Context to Internal Data Assets
Molecular structure representing AI-supported antibody design for blood-brain barrier research
How BBB-Penetrating Antibodies Cross the Blood-Brain Barrier
Life sciences conference takeaways 2026 - AACR, PEGS Boston, SLAS Europe, and Bio-IT World summary on AI in drug discovery
What 4 Life Sciences Conferences Revealed About AI in Drug Discovery
Life sciences professional using a tablet in front of digital data infrastructure screens
Scaling AI in Life Sciences: Why Data Infrastructure Determines Success

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!